MicroRNA-20b and ERK1/2 pathway independently regulate the expression of tissue factor in hematopoietic and trophoblastic differentiation of human embryonic stem cells

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Yu, Yan Hui ^a   Wu, Deng Shu ^a   Huang, Fang Fang ^a   Zhang, Zheng ^b   Liu, Lin Xin ^a   Zhang, Jian ^a   Zhan, Hui En ^a   Peng, Min Yuan ^a   Zeng, Hui ^a   Chen, Fang Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 20B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; THROMBOPLASTIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TROPHOBLAST; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; BUTADIENES; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GRANULOCYTES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; NITRILES; RNA, MESSENGER; SEQUENCE ALIGNMENT; THROMBOPLASTIN; TROPHOBLASTS;

EID: 84885358583     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt332     Document Type: Article

References (31)

1. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Orthner CL, Rodgers GM, Fitzgerald LA, Blood 1995 86 436 443 7605983
2. Cellular and molecular mechanisms of coronary vessel development. Mu H, Ohashi R, Lin P, Yao Q, Chen C, Vasc Med 2005 10 37 44 10.1191/1358863x05vm584ra 15920999 (Pubitemid 40667585)
3. Tissue factor in cancer progression and angiogenesis. Ruf W, Yokota N, Schaffner F, Thromb Res 2010 125 36 S38 20434002
4. Tissue factor storage, synthesis and function in normal and activated human platelets. Mezzano D, Matus V, Saez CG, Pereira J, Panes O, Thromb Res 2008 122 31 S36 18691497
5. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr, Blood 1996 88 1583 1587 8781413 (Pubitemid 26307052)
6. Tissue factor in hemostasis and thrombosis. Tilley R, Mackman N, Semin Thromb Hemost 2006 32 5 10 10.1055/s-2006-933335 16479457
7. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Redecha P, van Rooijen N, Torry D, Girardi G, Blood 2009 113 4101 4109 10.1182/blood-2008-12-194258 19234141
8. Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1 + 2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Kornberg A, Rahimi-Levene N, Yona R, Mor A, Rachmilewitz EA, Am J Hematol 1997 56 5 11 10.1002/(SICI)1096-8652(199709)56: 1<5::AID-AJH2>3.0.CO;2-U 9298860 (Pubitemid 27398051)
9. Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon. Nijziel M, van Oerle R, van 't Veer C, van Pampus E, Lindhout T, Hamulyak K, Br J Haematol 2001 112 98 104 10.1046/j.1365-2141.2001.02545.x 11167790 (Pubitemid 32151156)
10. Downregulation of tissue factor (TF) by RNA interference induces apoptosis and impairs cell survival of primary endothelium and tumor cells. Osterholm C, Li S, Ekberg H, Hedner U, Holgersson J, Cell Tissue Res 2008 334 93 102 10.1007/s00441-008-0650-4 18665396
11. Tissue factor in infection and severe inflammation. Levi M, van der Poll T, ten Cate H, Semin Thromb Hemost 2006 32 33 39 10.1055/s-2006-933338 16479460
12. Fractalkine-mediated endothelial cell injury by NK cells. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T, Imai H, Yoshie O, Bloom ET, Domae N, Umehara H, J Immunol 2000 164 4055 4062 10754298 (Pubitemid 30215060)
13. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK, Pendurthi UR, Rao LV, Blood 2004 103 3029 3037 10.1182/blood-2003-10-3417 15070680 (Pubitemid 38451676)
14. Differential gene expression in the amnion, chorion, and trophoblast of the human placenta. Plouzek CA, Leslie KK, Stephens JK, Chou JY, Placenta 1993 14 277 285 10.1016/S0143-4004(05)80427-8 8367411 (Pubitemid 23218290)
15. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N, Thromb Haemost 2004 92 776 786 15467908 (Pubitemid 39386704)
16. Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Goustin AS, Betsholtz C, Pfeifer-Ohlsson S, Persson H, Rydnert J, Bywater M, Holmgren G, Heldin CH, Westermark B, Ohlsson R, Cell 1985 41 301 312 10.1016/0092-8674(85)90083-2 2986848 (Pubitemid 15068447)
17. Role of tissue factor in embryonic blood vessel development. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D, Nature 1996 383 73 75 10.1038/383073a0 8779717 (Pubitemid 26296462)
18. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N, Blood 2005 105 2777 2782 10.1182/blood-2004-09-3724 15598816 (Pubitemid 40446269)
19. MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis. Tripurani SK, Lee KB, Wee G, Smith GW, Yao J, BMC Dev Biol 2011 11 25 10.1186/1471-213X-11-25 21548929
20. Getting to the root of miRNA-mediated gene silencing. Eulalio A, Huntzinger E, Izaurralde E, Cell 2008 132 9 14 10.1016/j.cell.2007.12.024 18191211
21. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. Zhang X, Yu H, Lou JR, Zheng J, Zhu H, Popescu NI, Lupu F, Lind SE, Ding WQ, J Biol Chem 2011 286 1429 1435 10.1074/jbc.M110.146530 21059650
22. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW, Blood 2005 105 1734 1741 10.1182/blood-2004-05-2042 15494427 (Pubitemid 40223697)
23. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N, Blood 2001 98 1429 1439 10.1182/blood.V98.5.1429 11520792
24. The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. Etscheid M, Beer N, Dodt J, Cell Signal 2005 17 1486 1494 10.1016/j.cellsig.2005.03.007 16153533 (Pubitemid 41253988)
25. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA, Dev Biol 2000 227 271 278 10.1006/dbio.2000.9912 11071754
26. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA, Nat Biotechnol 2002 20 1261 1264 10.1038/nbt761 12426580 (Pubitemid 35462493)
27. Human embryonic stem cell-derived CD34§ssup§+§esup§ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Vodyanik MA, Bork JA, Thomson JA, Slukvin II, Blood 2005 105 617 626 10.1182/blood-2004-04-1649 15374881 (Pubitemid 40070744)
28. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H, Lu H, J Hematol Oncol 2012 5 16 10.1186/1756-8722-5-16 22534171
29. Functional characterization of HUVEC-CS: Ca§ssup§2+§ esup§ signaling, ERK 1/2 activation, mitogenesis and vasodilator production. Gifford SM, Grummer MA, Pierre SA, Austin JL, Zheng J, Bird IM, J Endocrinol 2004 182 485 499 10.1677/joe.0.1820485 15350190 (Pubitemid 39276216)
30. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, Zhao JJ, Mao SS, Zhang GH, Xu XC, Zhang N, Cancer 2011 117 2842 2852 10.1002/cncr.25860 21692045
31. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways. Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ, Vinten-Johansen J, J Surg Res 2011 169 319 327 10.1016/j.jss.2010.01.041 20451919